COLUMBIA LABORATORIES INC
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: COLUMBIA LABORATORIES INC, 10-Q, 2000-08-14
Next: EPIMMUNE INC, 10-Q, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         9,221,413
<SECURITIES>                                   0
<RECEIVABLES>                                  2,755,938
<ALLOWANCES>                                   (428,757)
<INVENTORY>                                    1,468,412
<CURRENT-ASSETS>                               13,787,059
<PP&E>                                         2,484,903
<DEPRECIATION>                                 (1,664,193)
<TOTAL-ASSETS>                                 16,785,013
<CURRENT-LIABILITIES>                          3,123,171
<BONDS>                                        0
                          0
                                    59
<COMMON>                                       304,778
<OTHER-SE>                                     3,357,005
<TOTAL-LIABILITY-AND-EQUITY>                   16,785,013
<SALES>                                        5,705,955
<TOTAL-REVENUES>                               5,705,955
<CGS>                                          2,100,165
<TOTAL-COSTS>                                  2,100,165
<OTHER-EXPENSES>                               5,789,033
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             377,676
<INCOME-PRETAX>                                (2,537,776)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (2,537,776)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (2,537,776)
<EPS-BASIC>                                    (.04)
<EPS-DILUTED>                                  (.04)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission